Basit öğe kaydını göster

Alternative therapies for neonatal autoimmune thrombocytopenia

dc.contributor.authorSamanci, N
dc.contributor.authorDagoglu, T
dc.contributor.authorErmis, B
dc.contributor.authorAkdogan, Z
dc.contributor.authorOvali, F
dc.date.accessioned2021-03-04T12:32:32Z
dc.date.available2021-03-04T12:32:32Z
dc.date.issued1998
dc.identifier.citationOvali F., Samanci N., Ermis B., Akdogan Z., Dagoglu T., "Alternative therapies for neonatal autoimmune thrombocytopenia", VOX SANGUINIS, cilt.74, sa.3, ss.198-200, 1998
dc.identifier.issn0042-9007
dc.identifier.otherav_77d571c8-34fa-40b5-89aa-7b961f860540
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/82239
dc.identifier.urihttps://doi.org/10.1159/000030931
dc.description.abstractObjective: This study was performed to test whether corticosteroids were superior to intravenous immunoglobulins (IVIG) in the treatment of neonatal autoimmune thrombocytopenia (NAT). Methods: All cases received IVIG, and unresponsive cases received corticosteroids. Results: Of 7 babies who received IVIG, only 1 responded. The 6 remaining cases received corticosteroids thereafter, and all of them responded well to this therapy. Conclusions: Corticosteroids may be more effective than IVIG in NAT.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleAlternative therapies for neonatal autoimmune thrombocytopenia
dc.typeMakale
dc.relation.journalVOX SANGUINIS
dc.contributor.department, ,
dc.identifier.volume74
dc.identifier.issue3
dc.identifier.startpage198
dc.identifier.endpage200
dc.contributor.firstauthorID119960


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster